ArticleMedicina oral, patologia oral y cirugia bucal2025
Evolution of oral and oropharyngeal cancer in the Basque Country (Spain) from 1986-1994 to 2012-2017.
Article in Medicina oral, patologia oral y cirugia bucal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Changes in gingival cancer: burden of hospitalization and epidemiological evolution from 2001 to 2023 in Spain. a novel approach using hospital activity registry data.BMC oral health · 2026Article
- Geographic inequalities and gender-specific trends in oropharyngeal cancer mortality in Spain.Medicina oral, patologia oral y cirugia bucal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Basque Country (Spain) is one of the European regions with the highest incidence of oral and oropharyngeal cancer, which still shows an unacceptably poor prognosis. The aim of this study was to update the epidemiological and prognostic data on oral cancer in the Basque Country and to analyse its evolution with respect to a previous study carried out in 1986-1994. MATERIAL AND
methodsThis retrospective study included all cases diagnosed with oral and oropharyngeal cancer in the Basque Country from 2012 to 2017, obtained from the Cancer Population Registry. Descriptive analysis of the epidemiological data on oral-oropharyngeal cancer and survival analysis of oral squamous cell carcinoma were performed.
resultsA total of 1,762 cases of oral-oropharyngeal cancer were analysed. The crude incidence was 7.21 cases in women and 18.07 in men. We recognised an increase in females, older patients and gingival neoplasms. Squamous cell carcinomas accounted for 92.6% of the tumours, with 70.4% affecting males, 91.8% living in urban areas, and 50.2% diagnosed at advanced stages. The overall 5-year survival rate for oral-oropharyngeal cancer in the Basque Country was 50.2%.
conclusionsOral and oropharyngeal cancer incidence in the Basque Country has decreased overall, although it shows a progressive increase in women, older people and tumours located in the gingiva. The prognosis of oral cancer in the Basque Country is still very poor, thus it is necessary to implement specific preventive and diagnostic protocols to improve it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.